Hypertension as a Cause of Heart Failure

Pathophysiological Mechanism

Chronic hypertension leads to left ventricular hypertrophy, cardiac remodeling, and eventual progression to symptomatic heart failure, occurring through increased hemodynamic stress on the ventricle, neurohormonal activation, and structural changes that precede symptoms by months or years 1, 2, 3.
Hypertension contributes to both heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF), though the mechanisms differ 4.

Hypertension is an important contributor to acute heart failure decompensation, particularly among certain populations, such as blacks, women, and those with HFpEF 5, 6.
Almost 50% of patients admitted with acute heart failure had blood pressure >140/90 mmHg, with uncorrected high blood pressure and abrupt discontinuation of antihypertensive therapy being common precipitants of acute decompensated heart failure 5, 6.

Optimal blood pressure control decreases the risk of new heart failure by approximately 50% across multiple large controlled studies, with the American Heart Association recommending blood pressure control in accordance with contemporary guidelines to lower the risk of developing heart failure (Class I; Level of Evidence A) 1, 2, 7, 4.
Blood pressure should be controlled to prevent heart failure development, with target blood pressure <140/90 mmHg for patients <60 years or with chronic kidney disease/diabetes, and <150/90 mmHg for patients ≥60 years 7, 4.

The American College of Cardiology recommends lifestyle modifications including sodium restriction, weight reduction, heart-healthy diet, and moderation of alcohol intake to prevent heart failure 7, 4.
Patients with HFrEF should be treated with guideline-directed medical therapy (GDMT) including diuretics, ACE inhibitors or ARBs, beta-blockers, and aldosterone receptor antagonists (Class I; Level of Evidence A) 7, 4.
Nondihydropyridine calcium channel blockers (verapamil, diltiazem) and moxonidine are contraindicated in heart failure patients with hypertension (Class III: Harm), and alpha-adrenergic blockers like doxazosin should be avoided and used only if other drugs are inadequate at maximum tolerated doses (Class III: Harm) 7, 4.

The American Heart Association suggests that hypertension is a major cause of heart failure, with 91% of patients who develop heart failure having pre-existing hypertension, making it the most important preventable risk factor for heart failure development 8, 9
Elevated systolic and diastolic blood pressure are major risk factors for developing heart failure, with hazard ratios 2-fold higher in hypertensive men and 3-fold higher in hypertensive women compared to normotensives 8, 9

The American College of Cardiology recommends noting that hypertension accounted for 39% of heart failure cases in men and 59% in women, with hypertension antedating the development of heart failure in the vast majority of cases 10, 11
The lifetime risk of developing hypertension in the United States exceeds 75%, making prevention and treatment of hypertension the most vital strategy for preventing heart failure 10, 11

Optimal blood pressure control decreases the risk of new heart failure by approximately 50% across multiple large controlled studies and meta-analyses 10, 11, 12
Each 10 mmHg reduction in systolic blood pressure reduces incident heart failure risk by 17% 13
In patients who have had a prior myocardial infarction, treating hypertension produces even more dramatic benefits, with an 81% reduction in heart failure incidence 10, 11

The American Heart Association suggests targeting blood pressure <140/90 mm Hg for patients <60 years or with chronic kidney disease/diabetes, and <150/90 mm Hg for patients ≥60 years to prevent heart failure development 8, 14

ACE inhibitors reduce heart failure risk significantly, while calcium antagonists do not, despite both reducing overall cardiovascular events 8, 14
Diuretic-based therapy, ACE inhibitors, ARBs, and beta-blockers all effectively prevent heart failure by approximately 50% 15, 13
Calcium channel blockers and alpha-blockers are less effective in preventing heart failure syndrome, though they control blood pressure 10, 16